Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Viability and Safety of Early Discharge Protocol After TAVI Implantation

NCT05758909 is registered in ClinicalTrials.gov with Fundación EPIC as lead sponsor.

NCT NCT05758909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05758909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Viability and Safety of Early Discharge Protocol After TAVI Implantation
Lead sponsor
Fundación EPIC
Phase
Observational
Overall status
Active, not recruiting
Start date
April 4, 2023
Completion date
December 1, 2026
Enrollment
585 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve disease, aortic valve stenosis, heart valve diseases